Analytical Data
-
Gene name
ANP32C
- Application
-
Alternative Names
AN32C_HUMAN; ANP32 C; ANP32C; PhosphoProtein 32 related Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O43423
-
Expression Region
1-234aa
-
AA Sequence
MEMGRRIHSE LRNRAPSDVK ELALDNSRSN EGKLEALTDE FEELEFLSKI NGGLTSISDL PKLKLRKLEL RVSGGLEVLA EKCPNLTHLY LSGNKIKDLS TIEPLKQLEN LKSLDLFNCE VTNLNDYGEN VFKLLLQLTY LDSCYWDHKE APYSDIEDHV EGLDDEEEGE HEEEYDEDAQ VVEDEEGEEE EEEGEEEDVS GGDEEDEEGY NDGEVDGEED EEELGEEERG QKRK
-
Molecular Weight
26 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANP32C, a member of the Acidic Nucleophosmin-like Protein (ANP) family, has gained attention due to its potential roles in various cellular processes, including cell cycle regulation, apoptosis, and differentiation. Research on ANP32C is largely motivated by its implications in cancer biology and neurodevelopmental disorders. Recent studies have indicated that ANP32C may act as a key regulator in modulating the activity of specific protein complexes involved in transcriptional regulation and chromatin remodeling. For instance, its interaction with the viral oncogene proteins has been noted as a significant aspect of tumor proliferation. Moreover, ANP32C's expression patterns in different tissues suggest its involvement in essential neural processes, thus spurring investigations into its functionality within neurogenesis and synaptic plasticity. Furthermore, the development of recombinant ANP32C protein has enabled the exploration of its structural properties and interactions at a molecular level, offering potential therapeutic insights. Overall, the study of ANP32C recombinant protein is poised to enhance our understanding of its biological roles and therapeutic applications, making it a promising candidate for further research in health and disease.
